SiRNA-HMGA2 weakened AGEs-induced epithelial-to-mesenchymal transition in tubular epithelial cells

Biochemical and Biophysical Research Communications

Volumn 457, Issue 4, 2015, Pages 730-735

  Bai, Yi Hua ^a   Wang, Jia Ping ^a   Yang, Min ^a   Zeng, Yi ^a   Jiang, Hong Ying ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

AGEs; EMT; HMGA2

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA SMOOTH MUSCLE ACTIN; HIGH MOBILITY GROUP A2 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; UVOMORULIN; VIMENTIN;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA DAMAGE; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; IN VITRO STUDY; KIDNEY TUBULE EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UPREGULATION; ANIMAL; CELL LINE; EPITHELIUM CELL; GENETICS; METABOLISM; RAT;

ANIMALS; CELL LINE; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GLYCOSYLATION END PRODUCTS, ADVANCED; HMGA2 PROTEIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84922694268     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.01.063     Document Type: Article

References (20)

1. J.L. Gross, M.J. de Azevedo, and S.P. Silveiro Diabetic nephropathy: diagnosis, prevention, and treatment Diabetes Care 28 2005 164 176
2. F.C. Brosius 3rd, and C.E. Alpers New targets for treatment of diabetic nephropathy: what we have learned from animal models Curr. Opin. Nephrol. Hypertens. 22 2013 17 25
3. A.E. Raptis, and G. Viberti Pathogenesis of diabetic nephropathy Exp. Clin. Endocrinol. Diabetes 109 2001 S424 S437
4. Q. Wei, X. Ren, and Y. Jiang Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress BMC Cardiovasc. Disord. 13 2013 13
5. G. Basta, A.M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc. Res. 63 2004 582 592
6. C. Prasad, V. Imrhan, and F. Marotta Lifestyle and advanced glycation end products (AGEs) Burden: its relevance to Healthy aging Aging Dis. 5 2014 212 217
7. Y. Ishibashi, T. Matsui, and M. Takeuchi Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression Horm. Metab. Res. 44 2012 891 895
8. A.L. Tan, J.M. Forbes, and M.E. Cooper AGE, RAGE, and ROS in diabetic nephropathy Semin. Nephrol. 27 2007 130 143
9. J. Roche, P. Nasarre, and R. Gemmill Global decrease of histone H3K27 acetylation in ZEB1-induced epithelial to mesenchymal transition in lung Cancer cells Cancers (Basel) 5 2013 334 356
10. Y.S. Yang, C.J. Wang, and C.N. Huang Polyphenols of Hibiscus sabdariffa improved diabetic nephropathy via attenuating renal epithelial mesenchymal transition J. Agric. Food Chem. 61 2013 7545 7551
11. J. Wu, Z. Liu, and C. Shao HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes Cancer Res. 71 2011 349 359
12. J. Wang, J.Z. Li, and A.X. Lu Anticancer effect of salidroside on A549 lung cancer cells through inhibition of oxidative stress and phospho-p38 expression Oncol. Lett. 7 2014 1159 1164
13. J.W. Antoon, A.M. Nitzchke, and E.C. Martin Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition Int. J. Oncol. 42 2013 1139 1150
14. I. Cleynen, and W.J. Van de Ven The HMGA proteins: a myriad of functions (review) Int. J. Oncol. 32 2008 289 305
15. D. Califano, S. Pignata, and N.S. Losito High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer J. Cell. Physiol. 229 2014 53 59
16. A. Morishita, M.R. Zaidi, and A. Mitoro HMGA2 is a driver of tumor metastasis Cancer Res. 73 2013 4289 4299
17. M.S. Kumar, E. Armenteros-Monterroso, and P. East HMGA2 functions as a competing endogenous RNA to promote lung cancer progression Nature 505 2014 212 217
18. M.H. Müller, N. Drieschner, and T. Focken HMGA2 expression in the PC-3 prostate cancer cell line is autonomous of growth factor stimulation Anticancer Res. 33 2013 3069 3078
19. Y. Hu, K. He, and D. Wang TMEPAI regulates EMT in lung cancer cells by modulating the ROS and IRS-1 signaling pathways Carcinogenesis 34 2013 1764 1772
20. Torres M Mitogen-activated protein kinase pathways in redox signaling Front. Biosci. 8 2003 369 391